JAMI DEVARONA: Open Payments
NPI 1356415491 · GRAND LEDGE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,060 in 123 payments from 26 companies in 2025. Trend: 2023 $2,684 · 2024 $2,247 · 2025 $2,060
Food & beverage: $2,060
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $316 |
| ABBVIE INC. | 28 | $269 |
| GlaxoSmithKline, LLC. | 11 | $206 |
| PFIZER INC. | 13 | $193 |
| Axsome Therapeutics, Inc. | 7 | $158 |
| AstraZeneca Pharmaceuticals LP | 2 | $142 |
| Amgen Inc. | 8 | $128 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $94 |
| Lilly USA, LLC | 5 | $85 |
| Merck Sharp & Dohme LLC | 3 | $61 |
Products named: VRAYLAR, TRELEGY ELLIPTA, Auvelity, NURTEC ODT, Wegovy, Ozempic, FARXIGA, Kerendia.
Industry payments across MI — which companies pay providers there.
